The Royalty Pharma plc (RPRX) ROIC is 15.7%, compared to the industry median of ((122.4%)) and the 5-year historical average of 159.3%.
The Royalty Pharma plc (RPRX) ROIC minus WACC is 11.0%, compared to the industry median of ((129.8%)) and the 5-year historical average of 155.1%.
The Royalty Pharma plc (RPRX) ROE is 4.9%, compared to the industry median of ((52.2%)) and the 5-year historical average of 13.1%.
The Royalty Pharma plc (RPRX) ROCE is 7.2%, compared to the industry median of ((51.2%)) and the 5-year historical average of 7.3%.